Nevzorova V A, Pestrikova T L, Kochetkova E A, Mokshina M V, Osvald M, Dutrele S, Massard Zh
Eksp Klin Gastroenterol. 2013(6):11-4.
To evaluate the indicators of arterial blood gasometry and levels of nitric oxide (NO) in exhaled breath of patients with liver cirrhosis (LC) in combination with COPD, and determine frequency of occurrence of hepatopulmonary syndrome (HPS). The comparison group consisted of 20 patients with COPD, control - 15 volunteers. Gas measurement was estimated by ABL 725 radiometer (Denmark).
We examined 57 patients with liver cirrhosis. The patients were divided into 2 groups: 1st--Patients with liver cirrhosis (n = 48), 2nd group--the CPU and COPD (n = 9). Comparison group consisted of 20 patients with COPD, control - 15 volunteers. The gasometry was evaluated by ABL 725 radiometer (Denmark). NO levels in exhaled air was estimated using the NIOX MINO (Sweden). Contrast electrocardiography was performed on ATL HDI 5000 (Bothell, WA, USA).
We found that the PaO2 was lower in the 2nd group compared with the control and with the 1st group (81.4 +/- 5.2; 95.5 +/- 5.3 and 94.5 +/- 5.1 mm Hg; p < 0.05), but the lowest PaO2 was in the group with COPD (68.4 mm Hg). AaDO2 was higher in the group with COPD (37.7 mm Hg). In the 2nd group this indicator was higher as compared with the control and with the 1st group (26.8 +/- 5.4; 8.2 +/- 4.5 and 14.9 +/- 5.2 mm Hg; p < 0.05). A strong negative correlation in the 1st and the 2nd groups between AaDO2 and PaO2 (r = -0.67 and r = -0.93; p < 0.05) was obtained. Content of NO in exhaled air was higher in the 1st and 2nd groups compared with control (18.7 +/- 4.1; 18,9 +/- 4.5 and 11.0 +/- 3.3 ppb; p < 0.05). Intrapulmonary shunts were detected in 3 patients in the 1st and 2nd groups.
The relationship between measures of blood gas composition showed the leading role of hypoxemia in increasing the risk of formation of HPS in the LC, especially when combined with COPD.
评估肝硬化(LC)合并慢性阻塞性肺疾病(COPD)患者的动脉血气分析指标及呼出气中一氧化氮(NO)水平,并确定肝肺综合征(HPS)的发生率。对照组为20例COPD患者,对照组为15名志愿者。气体测量由ABL 725辐射计(丹麦)进行评估。
我们检查了57例肝硬化患者。患者分为2组:第1组为肝硬化患者(n = 48),第2组为肝硬化合并COPD患者(n = 9)。对照组为20例COPD患者,对照组为15名志愿者。血气分析由ABL 725辐射计(丹麦)进行评估。呼出气中的NO水平使用NIOX MINO(瑞典)进行评估。在ATL HDI 5000(美国华盛顿州博塞尔)上进行对比心电图检查。
我们发现,与对照组和第1组相比,第2组的动脉血氧分压(PaO2)较低(81.4±5.2;95.5±5.3和94.5±5.1 mmHg;p < 0.05),但最低的PaO2出现在COPD组(68.4 mmHg)。COPD组的肺泡动脉氧分压差(AaDO2)较高(37.7 mmHg)。与对照组和第①组相比,第②组的该指标更高(26.8±5.4;8.2±4.5和14.9±5.2 mmHg;p < 0.05)。在第1组和第2组中,AaDO2与PaO2之间存在强烈的负相关(r = -0.67和r = -0.93;p < 0.05)。与对照组相比,第1组和第2组呼出气中的NO含量更高(18.7±4.1;18.9±4.5和11.0±3.3 ppb;p < 0.05)。在第1组和第2组中,有3例患者检测到肺内分流。
血气成分测量之间的关系表明,低氧血症在增加LC患者发生HPS的风险中起主导作用,尤其是在合并COPD时。